87
Participants
Start Date
July 24, 2017
Primary Completion Date
May 31, 2024
Study Completion Date
May 31, 2024
MRI guided transurethral HIFU ablation of prostatic tissue
The technology is developed to ablate targeted benign and malignant prostate tissue through transurethrally inserted probe that transmit ultrasound energy under MRI guidance and control. The therapeutic endpoint of this method is thermal coagulation of prostate tissue.
Department of Urology, Turku
University of Turku
OTHER
Turku University Hospital
OTHER_GOV